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Lymphocyte Populations and Antibody Production in Vaccinated and
Non-vaccinated Pigs Challenged with Mycoplasma hyopneumoniae
Abstract
Mycoplasma hyopneumoniae (M. hyo), the cause of enzootic pneumonia in swine, is a worldwide problem.
Despite the developmental vaccines that have been commercially available for several years, M. hyo-induced
pneumonia is still a major concern to swine producers. The pathologic lesions observed with enzootic
pneumonia consist primarily of a lymphoid cell infiltration of the lungs. Four groups of pigs consisting of
challenge control, vaccinated and challenged, vaccinated only, and nonvaccinated and non-challenged were
used in this study. Lymphocytes from the peripheral blood, lung, and bronchial lymph nodes were analyzed
by flow cytometry (FACs) to determine the populations of cells activated by M. hyo. No significant difference
in percentages of B or T lymphocytes was found between the vaccinated and nonvaccinated groups. An
ELISPOT assay was used to evaluate the isotype of antibodies secreted by B lymphocytes from the same
tissues. Total secreted immunoglobulin and mycoplasmal membrane specific immunoglobulin secretion were
measured. A significant increase in secretion of total IgG by lymphocytes in the lungs of pigs only challenged
with M. hyo, and vaccinated/challenged was observed. No mycoplasma-specific stimulation was observed.
The mycoplasmal membrane preparation induced a non-specific stimulation by IgM secreting cells in all
groups. Again, no mycoplasma-specific response was observed. These results suggest that although
IgGsecreting lymphocytes are stimulated to secrete antibodies in infected pigs, the lymphocyte response
observed in enzootic pneumonia may not be to the M. hyo membrane antigen. At this time, it is unknown
whether the immune response to M. hyo is predominately an antibody- or cellmediated immune response,
and how these immune responses contribute to protection from enzootic pneumonia.
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Summary and Implications
Mycoplasma hyopneumoniae (M. hyo), the cause of
enzootic pneumonia in swine, is a worldwide problem.
Despite the developmental vaccines that have been
commercially available for several years, M. hyo-induced
pneumonia is still a major concern to swine producers. The
pathologic lesions observed with enzootic pneumonia
consist primarily of a lymphoid cell infiltration of the
lungs. Four groups of pigs consisting of  challenge control,
vaccinated and challenged, vaccinated only, and non-
vaccinated and non-challenged were used in this study.
Lymphocytes from the peripheral blood, lung, and
bronchial lymph nodes were analyzed by flow cytometry
(FACs) to determine the populations of cells activated by
M. hyo. No significant difference in percentages of B or T
lymphocytes was found between the vaccinated and non-
vaccinated groups. An ELISPOT assay was used to
evaluate the isotype of antibodies secreted by B lympho-
cytes from the same tissues. Total secreted immunoglobu-
lin and mycoplasmal membrane specific immunoglobulin
secretion were measured. A significant increase in secre-
tion of total IgG by lymphocytes in the lungs of pigs only
challenged with M. hyo, and vaccinated/challenged was
observed. No mycoplasma-specific stimulation was
observed. The mycoplasmal membrane preparation
induced a non-specific stimulation by IgM secreting cells
in all groups. Again, no mycoplasma-specific response was
observed. These results suggest that although IgG-
secreting lymphocytes are stimulated to secrete antibodies
in infected pigs, the lymphocyte response observed in
enzootic pneumonia may not be to the M. hyo membrane
antigen. At this time, it is unknown whether the immune
response to M. hyo is predominately an antibody- or cell-
mediated immune response, and how these immune
responses contribute to protection from enzootic pneumo-
nia.
Introduction
Enzootic pneumonia in swine caused by M. hyo
affects the majority of swine herds in the United States. M.
hyo infections result in a chronic pneumonia that often
leads to secondary bacterial pneumonia and decreased
growth rate. With the appearance of new pathogens such
as porcine reproductive and respiratory syndrome (PRRS)
virus, the severity of enzootic pneumonia has apparently
increased, thus becoming an even greater problem for
swine producers. Immunization induces serum antibodies,
but provides only partial protection against the develop-
ment of enzootic pneumonia and does not prevent coloni-
zation of M. hyo in the lungs. This indicates that other
immune mechanisms, such as cell mediated immunity or
secretory immunity may need to be stimulated to achieve
optimal protection against M. hyo. Because the influx of
lymphocytes into the lungs of mycoplasma infected pigs is
the primary pathologic lesion observed, identifying the
populations of these lymphocytes is important. In addition,
it may be possible to improve the protection against
enzootic pneumonia by identifying which populations of
lymphocytes need to be stimulated in vaccinated pigs
compared to pigs infected with M. hyo.
The objectives of this study were to compare the
populations of lymphocytes infiltrating the lungs of pigs
infected with M. hyo with pigs vaccinated against M. hyo
with a commercial bacterin and determine if the lympho-
cytes present in the lungs of pigs vaccinated and chal-
lenged with M. hyo differ from the cells which play a role
in protection. In addition, the isotype of immunoglobulins
secreted in response to mycoplasmal membrane antigen
was measured by ELISPOT assay.
Materials and Methods
Four groups of SPF mycoplasma-free pigs were used
in the study. The pigs were randomly assigned to the
groups with stratification by weight and sex. Each group
was housed individually in isolation rooms. Three-week-
old pigs in groups B and C were vaccinated with a
commercial M. hyo bacterin twice, two weeks apart,
according to the manufacturer’s directions. Three weeks
after the second vaccination, the pigs in Groups A and B
were challenged with 10 ml. of a 1-100 dilution of 10%
crude lung homogenate containing M. hyo.
The pigs were necropsied on day 28 post challenge,
and samples of peripheral blood, lung, and bronchial
lymph node was collected from each pig. Lymphocytes
were isolated from each of the samples by differential
centrifugation Histopaque, followed by washing and lysis
of contaminating erythrocytes. Lymphocytes then were
divided into two groups of cells: 1) assayed for their
expression of T and B cell surface glycoproteins using
FACs analysis, or 2) resuspended in media for the in vitro
ELISPOT assay to assess the number and isotype of
antibody secreting cells. Lesions on lung surfaces were
sketched and percentage of pneumonic lung was calculated
using a Zeiss image analysis system.
Results and Discussion
Pigs in group B, which received the vaccine were not
completely protected from M. hyo challenge. The percent-
age of lung tissue exhibiting lesions for pigs in group B
ranged from zero to 12.6% (mean = 3.4%)  as measured by
image analysis. All non-vaccinated and challenged pigs
receiving M. hyo inoculum had pneumonic lung lesions
(mean = 13.9%). None of the non-challenged pigs had
evidence of pneumonia.
No significant difference was found between the
populations of lymphocytes obtained from pigs in any of
the groups as determined by FACs analysis. The lack of
response by a specific population of lymphocytes suggests
that both B and T lymphocytes are stimulated by myco-
plasmal antigens.
Figure 1 depicts the total number of antibody secreting
cells in the peripheral blood, lung, and bronchial lymph
node identified by isotype. The lymphocytes in the lung
and bronchial lymph nodes from pigs in groups A and B
had significantly greater numbers of IgG secreting
lymphocytes. There was also a slight increase in the
number of IgM secreting cells in the bronchial lymph
nodes of groups A and B. These values suggest that M. hyo
stimulates lymphocytes to secrete predominantly IgG.
Figure 2 describes the number of antibody secreting
cells responding specifically to our mycoplasma mem-
brane preparation. There appears to be a non-specific
stimulation of IgM secreting  cells by the mycoplasmal
membrane preparation for all groups. Previous studies
have reported a non-specific mitogenicity by mycoplasmal
proteins. No
significant specific response to our mycoplasmal mem-
brane preparation was observed. There may have been a
slight increase in IgA secretion by lymphocytes in the
peripheral blood and the lung, however, no significant
difference was observed. No stimulation to the mycoplas-
mal membrane antigen was observed in the groups
immunized and/or challenged by M. hyo. The lack of
antigen-specific stimulation may be due to lack of recogni-
tion of our antigen, or an inadequate amount of protein
used in the ELISPOT assay. The protein concentration
utilized in the assay has been shown to induce lymphocyte
stimulation in previous studies. This suggests that the
mycoplasma membrane may not be very immunogenic on
its own. The response to other mycoplasma proteins will
need to be investigated to elucidate the immune responses
to M. hyo.
 The results of this study indicate that the lymphocytes
responding to M. hyo appear to be both B and T cells. This
suggests that both the cellular and humoral immune
systems proliferate in response to M. hyo. There were
significantly more lymphocytes secreting IgG in the lungs
of pigs challenged with M. hyo, suggesting that B cells are
responding to the mycoplasmal antigens. However, the
lack of a membrane-specific response suggests a possible
barrier to developing effective mycoplasma vaccines. The
induction of a non-specific response by IgM secreting cells
suggests that the mycoplasmal membrane preparation may
have some superantigen effect which also may interfere
with the immune response to M. hyo. The development of
this ELISPOT assay will allow us to begin investigating
the response by specific populations of lymphocytes to
various mycoplasmal proteins. The knowledge obtained in
these studies should aid in the development of more
effective vaccines against M. hyo.
Figure 1. Number of total antibody secreting cells in the peripheral blood (PBMC), lung, and bronchial
lymph node of M. hyo challenged (group A), vaccinated and challenged (group B), vaccinated (group C),
and non-vaccinated and non-challenged (group D) pigs measured by ELISPOT assay.
Figure 2. Number of M. hyo membrane specific antibody secreting cells in the peripheral blood
(PBMC), lung, and bronchial lymph node of M. hyo challenged (group A), vaccinated and challenged
(group B), vaccinated (group C), and non-vaccinated and non-challenged (group D) pigs measured by
ELISPOT assay. .
